Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer
Maria M. Rubinstein, Sherry Shen, Bradley J. Monk, David S.P. Tan, Angélica Nogueira‐Rodrigues, Daisuke Aoki, Jalid Sehouli, Vicky Makker
Topics & Concepts
MedicinePembrolizumabEndometrial cancerCarboplatinOncologyInternal medicineLenvatinibPaclitaxelCancerChemotherapyRetrospective cohort studyIntensive care medicineImmunotherapyCisplatinThyroid cancerEndometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentCancer Immunotherapy and Biomarkers